EMA Can Do More With Its Guidance On Multiplicity Issues In Clinical Trials, Says EFPIA

 
• By Vibha Sharma
  
Clinical trial
EFPIA Suggests Improvements To EMA’s Guidance On Multiplicity Issues In Trials • Source: Shutterstock

More from Clinical Trials

More from R&D